Bausch + Lomb Reports Strong Q3 2026 Growth and Debt Reduction
Bausch + Lomb (BLCO) reported robust third-quarter 2026 financial results, highlighted by an 8% constant-currency revenue increase to $1.375 billion. The company demonstrated significant operating leverage, with adjusted EBITDA margins expanding to 23.6% as high-margin product sales outpaced operating expenses. Key growth drivers included a nearly 70% surge in premium intraocular lens (IOL) sales and strong demand for prescription dry eye therapies. On the balance sheet, the company made substantial progress in deleveraging, reducing its net leverage ratio from 5.7x to 4.1x, supported by $233 million in quarterly operating cash flow. Management expressed confidence in reaching a long-term debt target of 3.5x. With rising full-year revenue and profit targets, the company is leveraging innovation in surgical and vision care segments to drive sustained long-term value.
Tickers: $BLCO
Topics: Debt Reduction EBITDA Margin Expansion Financial Performance Revenue Growth